Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2012 | 09-2012 | 06-2012 | 03-2012 | 12-2011 | |
| Sales | 0 | 0 | 200 | 469 | 2 |
| Gross Profit | N/A | N/A | 200 | 469 | 2 |
| Operating Expenses | 1,919 | 1,682 | 1,922 | 3,256 | 2,854 |
| Operating Income | -1,919 | -1,682 | -1,721 | -2,787 | -2,851 |
| Interest Expense | 235 | 274 | 103 | 256 | 456 |
| Other Income | -3,179 | 0 | 0 | 0 | -1,194 |
| Pre-tax Income | -5,333 | -1,956 | -1,824 | -3,042 | -4,500 |
| Income Tax | 2 | N/A | 2 | N/A | N/A |
| Net Income Continuous | -5,335 | -1,956 | -1,826 | -3,042 | -4,500 |
| Net Income | $-5,335 | $-1,956 | $-1,826 | $-3,042 | $-4,500 |
| EPS Basic Total Ops | -25.53 | -3.60 | -3.30 | -5.41 | -8.41 |
| EPS Basic Continuous Ops | -8.76 | -3.44 | -3.26 | -5.49 | -8.43 |
| EPS Diluted Total Ops | -25.53 | -3.60 | -3.30 | -5.41 | -8.41 |
| EPS Diluted Continuous Ops | -8.76 | -3.44 | -3.26 | -5.49 | -8.43 |
| EBITDA(a) | $-1,628 | $-1,636 | $-1,685 | $-2,779 | $-2,546 |